These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 17260953)
1. Localization of a conformational epitope common to non-native and fibrillar immunoglobulin light chains. O'Nuallain B; Allen A; Kennel SJ; Weiss DT; Solomon A; Wall JS Biochemistry; 2007 Feb; 46(5):1240-7. PubMed ID: 17260953 [TBL] [Abstract][Full Text] [Related]
2. Phage display and peptide mapping of an immunoglobulin light chain fibril-related conformational epitope. O'Nuallain B; Allen A; Ataman D; Weiss DT; Solomon A; Wall JS Biochemistry; 2007 Nov; 46(45):13049-58. PubMed ID: 17944486 [TBL] [Abstract][Full Text] [Related]
3. A model for amyloid fibril formation in immunoglobulin light chains based on comparison of amyloidogenic and benign proteins and specific antibody binding. Khurana R; Souillac PO; Coats AC; Minert L; Ionescu-Zanetti C; Carter SA; Solomon A; Fink AL Amyloid; 2003 Jun; 10(2):97-109. PubMed ID: 12964417 [TBL] [Abstract][Full Text] [Related]
4. Radioimaging of light chain amyloid with a fibril-reactive monoclonal antibody. Wall JS; Kennel SJ; Paulus M; Gregor J; Richey T; Avenell J; Yap J; Townsend D; Weiss DT; Solomon A J Nucl Med; 2006 Dec; 47(12):2016-24. PubMed ID: 17138745 [TBL] [Abstract][Full Text] [Related]
5. Bifunctional amyloid-reactive peptide promotes binding of antibody 11-1F4 to diverse amyloid types and enhances therapeutic efficacy. Wall JS; Williams AD; Foster JS; Richey T; Stuckey A; Macy S; Wooliver C; Campagna SR; Tague ED; Farmer AT; Lands RH; Martin EB; Heidel RE; Kennel SJ Proc Natl Acad Sci U S A; 2018 Nov; 115(46):E10839-E10848. PubMed ID: 30377267 [TBL] [Abstract][Full Text] [Related]
6. Differential recruitment efficacy of patient-derived amyloidogenic and myeloma light chain proteins by synthetic fibrils-A metric for predicting amyloid propensity. Martin EB; Williams A; Wooliver C; Heidel RE; Adams S; Dunlap J; Ramirez-Alvarado M; Blancas-Mejia LM; Lands RH; Kennel SJ; Wall JS PLoS One; 2017; 12(3):e0174152. PubMed ID: 28350808 [TBL] [Abstract][Full Text] [Related]
7. Recombinant immunoglobulin variable domains generated from synthetic genes provide a system for in vitro characterization of light-chain amyloid proteins. Stevens PW; Raffen R; Hanson DK; Deng YL; Berrios-Hammond M; Westholm FA; Murphy C; Eulitz M; Wetzel R; Solomon A Protein Sci; 1995 Mar; 4(3):421-32. PubMed ID: 7795526 [TBL] [Abstract][Full Text] [Related]
8. Analysis of somatic hypermutation and antigenic selection in the clonal B cell in immunoglobulin light chain amyloidosis (AL). Abraham RS; Geyer SM; Ramírez-Alvarado M; Price-Troska TL; Gertz MA; Fonseca R J Clin Immunol; 2004 Jul; 24(4):340-53. PubMed ID: 15163890 [TBL] [Abstract][Full Text] [Related]
9. AL amyloid imaging and therapy with a monoclonal antibody to a cryptic epitope on amyloid fibrils. Wall JS; Kennel SJ; Williams A; Richey T; Stuckey A; Huang Y; Macy S; Donnell R; Barbour R; Seubert P; Schenk D PLoS One; 2012; 7(12):e52686. PubMed ID: 23300743 [TBL] [Abstract][Full Text] [Related]
10. Production and immunodiagnostic applications of antihuman light chain monoclonal antibodies. Abe M; Goto T; Kennel SJ; Wolfenbarger D; Macy SD; Weiss DT; Solomon A Am J Clin Pathol; 1993 Jul; 100(1):67-74. PubMed ID: 7688492 [TBL] [Abstract][Full Text] [Related]
11. Incomplete Refolding of Antibody Light Chains to Non-Native, Protease-Sensitive Conformations Leads to Aggregation: A Mechanism of Amyloidogenesis in Patients? Morgan GJ; Usher GA; Kelly JW Biochemistry; 2017 Dec; 56(50):6597-6614. PubMed ID: 29200282 [TBL] [Abstract][Full Text] [Related]
12. Domain Interactions Determine the Amyloidogenicity of Antibody Light Chain Mutants. Weber B; Hora M; Kazman P; Pradhan T; Rührnößl F; Reif B; Buchner J J Mol Biol; 2020 Nov; 432(23):6187-6199. PubMed ID: 33058870 [TBL] [Abstract][Full Text] [Related]
13. Binding of nascent collagen by amyloidogenic light chains and amyloid fibrillogenesis in monolayers of human fibrocytes. Harris DL; King E; Ramsland PA; Edmundson AB J Mol Recognit; 2000; 13(4):198-212. PubMed ID: 10931557 [TBL] [Abstract][Full Text] [Related]
14. 2A4 binds soluble and insoluble light chain aggregates from AL amyloidosis patients and promotes clearance of amyloid deposits by phagocytosis Renz M; Torres R; Dolan PJ; Tam SJ; Tapia JR; Li L; Salmans JR; Barbour RM; Shughrue PJ; Nijjar T; Schenk D; Kinney GG; Zago W Amyloid; 2016 Sep; 23(3):168-177. PubMed ID: 27494229 [TBL] [Abstract][Full Text] [Related]
16. Light chain amyloidosis - current findings and future prospects. Baden EM; Sikkink LA; Ramirez-Alvarado M Curr Protein Pept Sci; 2009 Oct; 10(5):500-508. PubMed ID: 19538145 [TBL] [Abstract][Full Text] [Related]
17. Mass spectrometry characterization of light chain fragmentation sites in cardiac AL amyloidosis: insights into the timing of proteolysis. Lavatelli F; Mazzini G; Ricagno S; Iavarone F; Rognoni P; Milani P; Nuvolone M; Swuec P; Caminito S; Tasaki M; Chaves-Sanjuan A; Urbani A; Merlini G; Palladini G J Biol Chem; 2020 Dec; 295(49):16572-16584. PubMed ID: 32952127 [TBL] [Abstract][Full Text] [Related]
18. Localization of an idiotope on the L chain dimer and intact IgG1 immunoglobulin from the patient Mcg. Raison RL; Edmundson AB Mol Immunol; 1987 Sep; 24(9):937-43. PubMed ID: 3116412 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of immunoglobulin light chain amyloidosis with antibodies to the immunoglobulin light chain variable region. Hoshii Y; Kiyama M; Cui D; Kawano H; Ishihara T Pathol Int; 2006 Jun; 56(6):324-30. PubMed ID: 16704496 [TBL] [Abstract][Full Text] [Related]